An In Silico Approach Towards Identification of Novel Chalcone Derivatives as Potential Monoamine Oxidases Inhibitors

Publish Year: 1400
نوع سند: مقاله کنفرانسی
زبان: English
View: 115

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

IBIS10_177

تاریخ نمایه سازی: 5 تیر 1401

Abstract:

Parkinson's disease is a chronic and progressive neurological disorder of the central nervous system thataffects and disrupts the functioning of the body's motor system. In Parkinson's disease, Abnormalmitochondrial expression of the enzyme monoamine oxidases B (MAOB) causes the oxidation of compoundssuch as dopamine, serotonin, norepinephrine, ۲-phenylethylamine, etc. Oxidation of these compounds leadsto the production of reactive oxygen species, which by products ultimately lead to neurotoxic effects such asdisruption of neurotransmitters. Chalcones are unsaturated carbonyl α and β compounds that exhibit a varietyof biological effects. Recent studies show that chalcone derivatives also have good inhibitory effects on theMAOB enzyme. Today, various bioinformatics techniques are used in the manufacture and design ofmedicine to save time and money. Due to the need to develop inhibitory compounds that can selectively andreversibly have an inhibitory effect on the MAOB enzyme, in this study, we decided to design new chalconederivatives and study molecular docking and how they interact with the active site of the enzyme.

Keywords:

Monoamine Oxidases B (MAOB) , Molecular Docking , Chalcone Derivatives , Inhibitor

Authors

Reza Naderi

Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

Neda Adibpour

Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

Shohreh Mohebbi

Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

Hafezeh Salehabadi

Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran